VMP 13939111000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Memantine 20mg tablets
BNF code 0411000G0AAADAD
Virtual Therapeutic Moiety Memantine
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Memantine hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 20.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Ebixa 20mg tablets (Lundbeck Ltd)
Marixino 20mg tablets (Consilient Health Ltd)
Memantine 20mg tablets (A A H Pharmaceuticals Ltd)
Memantine 20mg tablets (Accord Healthcare Ltd)
Memantine 20mg tablets (Alliance Healthcare (Distribution) Ltd)
Memantine 20mg tablets (Bristol Laboratories Ltd)
Memantine 20mg tablets (Crescent Pharma Ltd)
Memantine 20mg tablets (Dawa Ltd)
Memantine 20mg tablets (DE Pharmaceuticals)
Memantine 20mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Memantine 20mg tablets (Macleods Pharma UK Ltd)
Memantine 20mg tablets (Medihealth (Northern) Ltd)
Memantine 20mg tablets (Niche Generics Ltd)
Memantine 20mg tablets (Sigma Pharmaceuticals Plc)
Memantine 20mg tablets (Torrent Pharma (UK) Ltd)
Memantine 20mg tablets (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Memantine 20mg tablets 28 tablet
Memantine 20mg tablets 7 tablet

dm+d data retrieved from TRUD: release NHSBSA_8.2.0_20220815000001, imported on 15th August 2022 at 04:48:25.